ethyl 4-(1-adamantanecarboxamido)benzoate | 303794-50-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: ethyl 4-(1-adamantanecarboxamido)benzoate
• 英文别名: Ethyl 4-(adamantane-1-carbonylamino)benzoate
• CAS: 303794-50-5
• 化学式: C₂₀H₂₅NO₃
• mdl: MFCD00666994
• 分子量: 327.423
• InChiKey: LRMBFLGWKNJJBL-UHFFFAOYSA-N

物化性质

• 熔点：
  192 °C(Solv: hexane (110-54-3))
• 沸点：
  513.2±33.0 °C(Predicted)
• 密度：
  1.225±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  1-金刚烷甲酸 在 氯化亚砜 、 三乙胺 作用下， 以 二氯甲烷 、 1,2-二氯乙烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 ethyl 4-(1-adamantanecarboxamido)benzoate
  参考文献：
  名称：

  Synthesis and microbiological evaluation of several benzocaine derivatives

  摘要：

  简历 以众所周知的麻醉剂苯佐卡因为起点，合成了十个衍生物，并通过紫外-可见光谱、红外光谱、核磁共振和元素分析进行了表征。这些化合物大多含有已知具有生物活性的残基，如烟酸（维生素B3或PP）、生物素（维生素B7或H）、硫辛酸（硫辛酸）、金刚烷，以及其他皇冠醚型、苯并呋咱、萘基脲、二硝基和三硝基苯以及硝基自由基的残基。对所得到的化合物进行了生物学评价，包括亲水性（脂亲性）测定、总抗氧化和微生物活性测试。 补充材料： 本文的补充材料以单独文件形式提供：mmc1.docx

  DOI：

  10.1016/j.crci.2013.03.012

文献信息

• Highly Chemoselective Transamidation of Unactivated Tertiary Amides by Electrophilic N−C(O) Activation by Amide‐to‐Acyl Iodide Re‐routing
  作者：Dongxu Zuo、Qun Wang、Long Liu、Tianzeng Huang、Michal Szostak、Tieqiao Chen

  DOI：10.1002/anie.202202794

  日期：2022.6.13

  The challenging transamidation of unactivated tertiary amides using equivalent amounts of amines has been accomplished via cooperative acid/iodide catalysis. The method provides a novel manifold to re-route the reactivity of unactivated and unreactive N,N-dialkyl amides through reactive acyl iodide intermediates, representing a powerful new activation mode of unactivated amide bonds.

  使用等量的胺对未活化的叔酰胺进行具有挑战性的转酰胺化反应是通过协同酸/碘化物催化完成的。该方法提供了一种新的方法，通过反应性酰碘中间体重新引导未活化和未反应性N,N-二烷基酰胺的反应性，代表了一种强大的未活化酰胺键的新活化模式。
• Structure−Activity Relationships of Cycloalkylamide Derivatives as Inhibitors of the Soluble Epoxide Hydrolase
  作者：In-Hae Kim、Yong-Kyu Park、Bruce D. Hammock、Kosuke Nishi

  DOI：10.1021/jm101431v

  日期：2011.3.24

  Structure-activity relationships of cycloalkylamide compounds as inhibitors of human sEH were investigated. When the left side of amide function was modified by a variety of cycloalkanes, at least a C6 like cyclohexane was necessary to yield reasonable inhibition potency on the target enzyme. In compounds with a smaller cycloalkane or with a polar group on the left side of amide function, no inhibition was observed. On the other hand, increased hydrophobicity dramatically improved inhibition potency. Especially, a tetrahydronaphthalene (20) effectively increased the potency. When a series of alkyl or aryl derivatives of cycloalkylamide were investigated to continuously optimize the right side of the amide pharmacophore, a benzyl moiety functionalized with a polar group produced highly potent inhibition. A nonsubstituted benzyl, alkyl, aryl, or biaryl structure present on the right side of the cycloalkylamide function induced a big decrease in inhibition potency. Also, the resulting potent cycloalkylamide (32) showed reasonable physical properties.
• Synthesis and microbiological evaluation of several benzocaine derivatives
  作者：Anca Paun、Irina Zarafu、Miron T. Caproiu、Constantin Draghici、Maria Maganu、Ani I. Cotar、Mariana C. Chifiriuc、Petre Ionita

  DOI：10.1016/j.crci.2013.03.012

  日期：2013.7

  Résumé Starting from benzocaine, a well-known anaesthetic, ten derivatives were synthesized and characterized by UV–vis, IR, NMR, and elemental analysis. Most of the compounds contain residues with recognized biological activity, like nicotinic acid (vitamin B3 or PP), biotin (vitamin B7 or H), lipoic acid (thioctic acid), adamantine, as well as other residues of crown-ether type, benzofurazane, naphtylurea, di- and tri-nitrobenzene, and a nitroxide radical. The biological evaluation of the obtained compounds included hydrophobicity (lipophobicity) assay, total antioxidant and microbiological activity tests. Supplementary Materials: Supplementary material for this article is supplied as a separate file: mmc1.docx

  简历 以众所周知的麻醉剂苯佐卡因为起点，合成了十个衍生物，并通过紫外-可见光谱、红外光谱、核磁共振和元素分析进行了表征。这些化合物大多含有已知具有生物活性的残基，如烟酸（维生素B3或PP）、生物素（维生素B7或H）、硫辛酸（硫辛酸）、金刚烷，以及其他皇冠醚型、苯并呋咱、萘基脲、二硝基和三硝基苯以及硝基自由基的残基。对所得到的化合物进行了生物学评价，包括亲水性（脂亲性）测定、总抗氧化和微生物活性测试。 补充材料： 本文的补充材料以单独文件形式提供：mmc1.docx